Spots Global Cancer Trial Database for A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia
Official Title: Phase II Trial to Evaluate The Efficacy of Obinutuzumab (RO5072759) + Bendamustine Treatment in Patients With Refractory Or Relapsed Chronic Lymphocytic Leukemia
Study ID: NCT02071225
Conditions
Study Description
Brief Summary: This phase II trial was designed to evaluate the efficacy of obinutuzumab and bendamustine treatment in participants with refractory or relapsed chronic lymphocytic leukemia (CLL). Participants receive up to six 28-day cycles of treatment. Treatment consists of intravenous (IV) administration of obinutuzumab and bendamustine. Treatment time is expected to last 6 months, and participant follow-up will last 2 years.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hospital De Txagorritxu; Servicio de Hematologia, Vitoria, Alava, Spain
Hospital General Universitario de Elche; Servicio de Hematologia, Elche, Alicante, Spain
Hospital de Cabueñes; Servicio de Hematología y Hemoterapia, Gijon, Asturias, Spain
Hospital Univ. Central de Asturias; servicio de Hematologia, Oviedo, Asturias, Spain
Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia, Badalona, Barcelona, Spain
Hospital Mutua de Terrassa; Servicio de Hematologia, Terrassa, Barcelona, Spain
Hospital de Navarra, Servicio de Hematología, Pamplona, Navarra, Spain
Complejo Hospitalario Nuestra Señora de la Candelaria; Servicio de Hematologia, Santa Cruz de Tenerife, Tenerife, Spain
Hospital Universitari Vall d'Hebron; Servicio de Hematologia, Barcelona, , Spain
Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona, , Spain
Hospital General de Castellon; Servicio de Hematologia, Castellon, , Spain
Hospital Universitario Virgen de las Nieves; Servicio de Hematologia, Granada, , Spain
Hospital de Gran Canaria Dr. Negrin; Servicio de Hematologia, Las Palmas, , Spain
Hospital Universitario la Paz; Servicio de Hematologia, Madrid, , Spain
Hospital Universitario Puerta de Hierro; Servicio de Hematologia, Madrid, , Spain
Hospital Costa del Sol; Servicio de Hematologia, Malaga, , Spain
Hospital Universitario Virgen Macarena; Servicio de Hematologia, Sevilla, , Spain
Hospital Univ. Nuestra Señora de Valme; Servicio de Hematologia, Sevilla, , Spain
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia, , Spain
Hospital Universitario Dr. Peset; Servicio de Hematologia, Valencia, , Spain
Hospital Clinico Universitario Lozano Blesa; Servicio de Hematologia, Zaragoza, , Spain
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
